Vaxcyte (PCVX) Operating Income (2019 - 2026)
Vaxcyte's Operating Income was -$302.78 million in Q2 2026, compared with -$226.22 million a year earlier.
Powered by 
Analysis
Vaxcyte (PCVX) Operating Income (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Vaxcyte's Operating Income was -$1.17 billion through Jun 30, 2026; for FY2025, it came in at -$923.68 million.
- In earlier years, Operating Income was -$569.55 million in FY2024, -$468.04 million in FY2023, -$232.26 million in FY2022 and -$103.67 million in FY2021.
- Quarterly Operating Income has moved between -$345.85 million (Q1 2026) and -$26.95 million (Q3 2021) over five years.
- Per Business Quant data, PCVX's Operating Income in the three quarters before Q2 2026 was -$345.85 million (Q1 2026), -$274.28 million (Q4 2025) and -$242.38 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,170.42 Bn | 1,139.01 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 648.22 Bn | 568.08 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 504.43 Bn | 477.54 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 369.14 Bn | 323.52 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 303.29 Bn | 267.28 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 268.21 Bn | 241.90 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 242.56 Bn | 197.96 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 194.91 Bn | 169.11 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 173.28 Bn | 119.92 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Vaxcyte | 9.08 Bn | 2.58 Bn | - | -302.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -302.78 Mn |
| Mar 31, 2026 | -345.85 Mn |
| Dec 31, 2025 | -274.28 Mn |
| Sep 30, 2025 | -242.38 Mn |
| Jun 30, 2025 | -226.22 Mn |
| Mar 31, 2025 | -180.79 Mn |
| Dec 31, 2024 | -162.17 Mn |
| Sep 30, 2024 | -139.92 Mn |
| Jun 30, 2024 | -152.98 Mn |
| Mar 31, 2024 | -114.47 Mn |
| Dec 31, 2023 | -196.68 Mn |
| Sep 30, 2023 | -113.03 Mn |
| Jun 30, 2023 | -87.15 Mn |
| Mar 31, 2023 | -71.19 Mn |
| Dec 31, 2022 | -86.57 Mn |
| Sep 30, 2022 | -58.58 Mn |
| Jun 30, 2022 | -47.89 Mn |
| Mar 31, 2022 | -39.22 Mn |
| Dec 31, 2021 | -29.85 Mn |
| Sep 30, 2021 | -26.95 Mn |
API Access
Vaxcyte Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=PCVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "PCVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=PCVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();